EUVIMEDOpdag EUVIMED
Open access

Prognostic value and immune landscapes of anoikis-associated lncRNAs in lung adenocarcinoma

Bo Wu, Xiang Zhang, Nan Feng, Zishun Guo, Lu Gao, Zhihua Wan, Wenxiong Zhang

Aging · 2024-02-05

DOI: 10.18632/aging.205481 ↗

At a glance

Journal article in Aging, published online on 2024-02-05. Written by Bo Wu and 6 co-authors. Institution: Department of Thoracic Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, China. Major MEDLINE topics: RNA, Long Noncoding, Adenocarcinoma, Lung Neoplasms. Cited 1 times so far (Crossref); 39 references. The full text is freely available in PubMed Central.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

BACKGROUND: Methods for predicting the outcome of lung adenocarcinoma (LUAD) in the clinic are limited. Anoikis is an important route to programmed cell death in LUAD, and the prognostic value of a model constructed with anoikis-related lncRNAs (ARlncRNAs) in LUAD is unclear. METHODS: Transcriptome and basic information for LUAD patients was obtained from the Cancer Genome Atlas. Coexpression and Cox regression analyses were utilized to identify prognostically significant ARlncRNAs and construct a prognostic signature. Furthermore, the signature was combined with clinical characteristics to create a nomogram. Finally, we performed principal component, enrichment, tumor mutation burden (TMB), tumor microenvironment (TME) and drug sensitivity analyses to evaluate the basic research and clinical merit of the signature. RESULTS: The prognostic signature developed with eleven ARlncRNAs can accurately predict that high-risk group patients have a worse prognosis, as proven by the receiver operating characteristic (ROC) curve (AUC: 0.718). Independent prognostic analyses indicated that the risk score is a significant independent prognostic element for LUAD (P

Subjects

MeSH terms (MEDLINE)

RNA, Long NoncodingAdenocarcinomaLung NeoplasmsHumansAnoikisPrognosisLungTumor Microenvironment

Author keywords

anoikisdrug sensitivitylncRNAslung adenocarcinomaoverall survival

Substances

RNA, Long Noncoding

Authors and institutions

  • Department of Thoracic Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, China.
  • Department of Thoracic Surgery, Baoding No.1 Central Hospital, Baoding 071000, China.

Cite

APA

Wu, B., Zhang, X., Feng, N., Guo, Z., Gao, L., Wan, Z., & Zhang, W. (2024). Prognostic value and immune landscapes of anoikis-associated lncRNAs in lung adenocarcinoma. Aging. https://doi.org/10.18632/aging.205481

Vancouver

Wu B, Zhang X, Feng N, Guo Z, Gao L, Wan Z, et al. Prognostic value and immune landscapes of anoikis-associated lncRNAs in lung adenocarcinoma. Aging. 2024. doi:10.18632/aging.205481

BibTeX
@article{Wu2024,
  author = {Wu, Bo and Zhang, Xiang and Feng, Nan and Guo, Zishun and Gao, Lu and Wan, Zhihua and Zhang, Wenxiong},
  title = {Prognostic value and immune landscapes of anoikis-associated lncRNAs in lung adenocarcinoma},
  journal = {Aging},
  year = {2024},
  doi = {10.18632/aging.205481}
}
Start for free →